Temporal trends in diagnosis,treatment,and outcome for non-ST-segment elevation acute coronary syndrome in three regions of China,2008–2015  

作　　者：Rong Liu Yu-Qing Sun Xiao-Xia Hou Yang Zheng Mark DHuffman Craig SAnderson Liu He Shi-Jun Xia Chao Jiang Xin Du Jian-Zeng Dong Chang-Sheng Ma 

机构地区：[1]Department of Research and Development,Heart Health Research Center(HHRC),Beijing,100029,China [2]Cardiovascular Program,The George Institute for Global Health,Faculty of Medicine,University of New South Wales,Sydney 2050,Australia [3]Department of Cardiology,Beijing Anzhen Hospital,Capital Medical University,Beijing 100029,China [4]Department of Cardiology,Beijing Tongren Hospital,Capital Medical University,Beijing100176,China [5]Department of Cardiology,The First Bethune Hospital of Jilin University,Changchun,Jilin 130021,China [6]Institute for Global Health,Northwestern University Feinberg School of Medicine,Chicago 60611,USA [7]Neurological Program,The George Institute for Global Health,Faculty of Medicine,University of New South Wales,Sydney 2050,Australia [8]Neurological Program,The George Institute China at Peking University Health Science Center,Beijing 100600,China [9]Department of Cardiology,The First Affiliated Hospital of Zhengzhou University,Zhengzhou,Henan 450052,China.

出　　处：《Chinese Medical Journal》2021年第16期1997-1999,共3页中华医学杂志（英文版）

基　　金：the National Key Research and Development Program of the Ministry of Science and Technology of China(2020YFC2004803);the Beijing Municipal Commission of Science and Technology(No.D171100006817001).

摘　　要：To the Editor:As acute coronary syndromes(ACS)is common causes of morbidity and mortality in China,they serve as an important case example to assess the impact of these health reforms on the quality,safety,and efficiency of healthcare.[1]ACS comprises a wide spectrum of disease subgroups,including ST-segment elevation myocardial infarction(STEMI),unstable angina(UA),and non-ST-segment elevation myocardial infarction(NSTEMI).Previous studies have shown increases in the intensity of testing and treatment while stable in-hospital mortality for STEMI in China between 2001 and 2011.[2]As non-ST-segment elevation acute coronary syndrome(NSTE-ACS)patients,who account for about two-thirds of ACS patients,have a wide spectrum of disease severity,risk-stratified management is recommended to ensure appropriate allocation of resources,especially in limited-resource settings of China.As limited data exist on the use of medical services and clinical outcomes in relation to health reforms,we aimed to determine temporal trends in diagnosis,treatment,and outcome for hospitalized NSTE-ACS patients in three regions of China between 2008 and 2015.

关 键 词：DIAGNOSIS UNSTABLE TREATMENT 

分 类 号：R541.4[医药卫生—心血管疾病]